Advertisement

The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis

      Abstract

      Purpose: Indwelling urinary catheters are implicated in most cases of nosocomial urinary tract infection. Silver-coating of catheters may reduce the risk of these infections; however, trials have provided mixed results. We performed a meta-analysis to estimate the effectiveness of silver-coated urinary catheters.
      Subjects and methods: Published or unpublished articles were sought using MEDLINE, reference review, and correspondence with original authors, catheter manufacturers, and experts. Trials using silver-coated urinary catheters in the treatment group and uncoated urinary catheters in the control group were included. Bacteriuria, as evaluated by urine culture, was the outcome variable used to indicate urinary tract infection. Summary odds ratios (OR) and 95% confidence intervals (CI) were calculated using Mantel-Haenszel methods with a fixed-effects model.
      Results: Of 117 reports retrieved, eight trials with a total of 2,355 patients satisfied inclusion criteria. The summary OR for urinary tract infection was 0.59 (95% CI, 0.42 to 0.84) indicating a significant benefit in the patients receiving silver-coated catheters. A test of heterogeneity, however, indicated that the odds ratios varied significantly among studies. Silver alloy catheters (OR = 0.24; 95% CI, 0.11 to 0.52) were significantly more protective against bacteriuria than silver oxide catheters (OR = 0.79; 95% CI, 0.56 to 1.10).
      Conclusions: This meta-analysis clarifies discrepant results among trials of silver-coated urinary catheters by revealing that silver alloy catheters are significantly more effective in preventing urinary tract infections than are silver oxide catheters. Though silver alloy urinary catheters cost about $6 more than standard urinary catheters, they may be worth the extra cost since catheter-related infection is a common cause of nosocomial infection and bacteremia.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Haley R.W
        • Hooton T.M
        • Culver D.H
        • et al.
        Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients.
        Am J Med. 1981; 70: 947-959
        • Garibaldi R.A
        • Burke J.P
        • Dickman M.L
        • Smith C.B
        Factors predisposing to bacteriuria during indwelling urethral catheterization.
        NEJM. 1974; 291: 215-219
        • Bryan C.S
        • Reynolds K.L
        Hospital-acquired bacteremic urinary tract infection.
        J Urol. 1984; 132: 494-498
        • Krieger J.N
        • Kaiser D.L
        • Wenzel R.P
        Urinary tract etiology of bloodstream infections in hospitalized patients.
        J Infect Dis. 1983; 148: 57-62
        • Platt R
        • Polk B.F
        • Murdock B
        • Rosner B
        Mortality associated with nosocomial urinary-tract infection.
        NEJM. 1982; 307: 637-642
        • Platt R
        • Polk B.F
        • Murdock B
        • Rosner B
        Reduction of mortality associated with nosocomial urinary tract infection.
        Lancet. 1983; 1: 893-897
        • Green M.S
        • Rubinstein E
        • Amit P
        Estimating the effects of nosocomial infections on the length of hospitalization.
        J Infect Dis. 1982; 145: 667-672
        • Givens C.D
        • Wenzel R.P
        Catheter-associated urinary tract infections in surgical patients.
        J Urol. 1980; 124: 646-648
        • Gabriel M.M
        • Mayo M.S
        • May L.L
        • et al.
        In vitro evaluation of the efficacy of a silver-coated catheter.
        Curr Microbiol. 1996; 33: 1-5
        • Liedberg H
        • Lundeberg T
        Silver coating of urinary catheters prevents adherence and growth of Pseudomonas aeruginosa.
        Urol Res. 1989; 17: 357-358
        • McLean R.J
        • Hussain A.A
        • Sayer M
        • et al.
        Antibacterial activity of multilayer silver-copper surface films on catheter material.
        Can J Microbiol. 1993; 39: 895-899
        • Warren J.W
        The catheter and urinary tract infection.
        Med Clin North Am. 1991; 75: 481-493
        • Stamm W.E
        Catheter-associated urinary tract infections.
        Am J Med. 1991; 91: 65S-71S
        • Yusuf S
        Obtaining medically meaningful answers from an overview of randomized clinical trials.
        Stat Med. 1987; 6: 281-294
        • Light R.J
        Accumulating evidence from independent studies.
        Stat Med. 1987; 6: 221-231
        • Hennekens C.H
        • Buring J.E
        • Hebert P.R
        Implications of overviews of randomized trials.
        Stat Med. 1987; 6: 397-409
        • Sacks H.S
        • Berrier J
        • Reitman D
        • et al.
        Meta-analyses of randomized controlled trials.
        NEJM. 1987; 316: 450-455
        • Daifuku R
        • Stamm W.E
        Association of rectal and urethral colonization with urinary tract infection in patients with indwelling catheters.
        JAMA. 1984; 252: 2028-2030
        • Gelber R.D
        • Goldhirsch A
        Interpretation of results from subset analyses within overviews of randomized clinical trials.
        Stat Med. 1987; 6: 371-388
        • Jadad A.R
        • Moore R.A
        • Carroll D
        • et al.
        Assessing the quality of reports of randomized clinical trials.
        Control Clin Trials. 1996; 17: 1-12
        • Moher D
        • Jadad A.R
        • Tugwell P
        Assessing the quality of randomized controlled trials. Current issues and future directions.
        Int J Technol Assess Health Care. 1996; 12: 195-208
        • Petitti D.B
        Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis. Oxford University Press, New York1994
        • Fleiss J.L
        The statistical basis of meta-analysis.
        Stat Methods Med Res. 1993; 2: 121-145
        • Draper N.R
        • Smith H
        Applied Regression Analysis. 2nd ed. Wiley, New York1981
        • Akiyama H
        • Okamoto S
        Prophylaxis of indwelling urethral catheter infection.
        J Urol. 1979; 121: 40-42
        • Nakada J
        • Kawahara M
        • Onodera S
        • Oishi Y
        Clinical study of Silver Lubricath Foley catheter.
        Hinyokika Kiyo. 1996; 42: 433-438
        • Lundeberg T
        Prevention of catheter-associated urinary-tract infections by use of silver-impregnated catheters.
        Lancet. 1986; 2 (Letter): 1031
        • Schaeffer A.J
        • Story K.O
        • Johnson S.M
        Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria.
        J Urol. 1988; 139: 69-73
        • Johnson J.R
        • Roberts P.L
        • Olsen R.J
        • et al.
        Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter.
        J Infect Dis. 1990; 162: 1145-1150
        • Liedberg H
        • Lundeberg T
        Silver alloy coated catheters reduce catheter-associated bacteriuria.
        Br J Urol. 1990; 65: 379-381
        • Liedberg H
        • Lundeberg T
        • Ekman P
        Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study.
        Eur Urol. 1990; 17: 236-240
        • Liedberg H
        • Lundeberg T
        Prospective study of incidence of urinary tract infection in patients catheterized with bard hydrogel and silver-coated catheters or bard hydrogel-coated catheters.
        J Urol. 1993; 149 (Abstract): 405A
        • Takeuchi H
        • Hida S
        • Yoshida O
        • Ueda T
        Clinical study on efficacy of a Foley catheter coated with silver-protein in prevention of urinary tract infections.
        Hinyokika Kiyo. 1993; 39: 293-298
        • Riley D.K
        • Classen D.C
        • Stevens L.E
        • Burke J.P
        A large randomized clinical trial of a silver-impregnated urinary catheter.
        Am J Med. 1995; 98: 349-356
        • Thompson S.G
        Why sources of heterogeneity in meta-analysis should be investigated.
        BMJ. 1994; 309: 1351-1355
        • Greenland S
        Invited commentary.
        Am J Epidemiol. 1994; 140: 290-296
        • Greenland S
        Quantitative methods in the review of epidemiologic literature.
        Epidemiol Rev. 1987; 9: 1-30
        • Liedberg H
        Catheter induced urethral inflammatory reaction and urinary tract infection. An experimental and clinical study.
        Scand J Urol Nephrol. 1989; 124: 1-43
        • Khan K.S
        • Daya S
        • Jadad A
        The importance of quality of primary studies in producing unbiased systematic reviews.
        Arch Intern Med. 1996; 156: 661-666
        • Schulz K.F
        • Chalmers I
        • Hayes R.J
        • Altman D.G
        Empirical evidence of bias. Dimensions of methodological quality associated with esti-mates of treatment effects in controlled trials.
        JAMA. 1995; 273: 408-412
        • Kunin C.M
        Urinary tract infections.
        Surg Clin North Am. 1980; 60: 223-231
        • Stark R.P
        • Maki D.G
        Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant?.
        NEJM. 1984; 311: 560-564
        • Stamm W.E
        Urinary tract infections.
        in: Bennett J.V Brachman P.S Hospitals Infections. 4th ed. Lippincott-Raven, Philadelphia1998: 481
        • Fleming T.R
        • DeMets D.L
        Surrogate end points in clinical trials.
        Ann Intern Med. 1996; 125: 605-613
        • Maki D.G
        Nosocomial bacteremia. An epidemiologic overview.
        Am J Med. 1981; 70: 719-732
        • Vincent J.L
        • Bihari D.J
        • Suter P.M
        • et al.
        The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.
        JAMA. 1995; 274: 639-644